| Title: | Colorectal cancer risk stratification using a polygenic risk score in symptomatic primary care patients - a UK Biobank retrospective cohort study |
| Journal: | European Journal of Human Genetics |
| Published: | 1 Aug 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39090236/ |
| DOI: | https://doi.org/10.1038/s41431-024-01654-3 |
Publication 12737
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. Accurate cancer risk assessment approaches could increase rates of early CRC diagnosis, improve health outcomes for patients and reduce pressure on diagnostic services. The faecal immunochemical test (FIT) for blood in stool is widely used in primary care to identify symptomatic patients with likely CRC. However, there is a 6-16% noncompliance rate with FIT in clinic and ~90% of patients over the symptomatic 10 µg/g test threshold do not have CRC. A polygenic risk score (PRS) quantifies an individual's genetic risk of a condition based on many common variants. Existing PRS for CRC have so far been used to stratify asymptomatic populations. We conducted a retrospective cohort study of 50,387 UK Biobank participants with a CRC symptom in their primary care record at age 40+. A PRS based on 201 variants, 5 genetic principal components and 22 other risk factors and markers for CRC were assessed for association with CRC diagnosis within 2 years of first symptom presentation using logistic regression. Associated variables were included in an integrated risk model and trained in 80% of the cohort to predict CRC diagnosis within 2 years. An integrated risk model combining PRS, age, sex, and patient-reported symptoms was predictive of CRC development in a testing cohort (receiver operating characteristic area under the curve, ROCAUC: 0.76, 95% confidence interval: 0.71-0.81). This model has the potential to improve early diagnosis of CRC, particularly in cases of patient noncompliance with FIT.</p>
13 Authors
- Bethan Mallabar-Rimmer
- Samuel W. D. Merriel
- Amy P. Webster
- Leigh Jackson
- Andrew R. Wood
- Matthew Barclay
- Jessica Tyrrell
- Katherine S. Ruth
- Christina Thirlwell
- Richard Oram
- Michael N. Weedon
- Sarah E. R. Bailey
- Harry D. Green
1 Application
| Application ID | Title |
|---|---|
| 74981 | Investigating the clinical utility of polygenic risk scores in investigating patients with symptoms of possible cancer in primary care |
Enabling scientific discoveries that improve human health